The incidence of Staphylococcus aureus ST8-USA300 among French pediatric inpatients is rising
Methicillin-resistant Staphylococcus aureus (MRSA) formerly colonized and infected only inpatients in hospitals, but have been reported in community settings worldwide over the last 20 years. In France, the prevalence of such MRSA remains low and outbreaks have, until now, been mainly due to the ST80 clone. However, there were two outbreaks of MRSA clone ST-USA300 recently in France, including one involving children. To investigate epidemiological developments, we studied the 77 MRSA isolated from pediatric patients hospitalized between 2008 and 2013 in three French hospitals. The median incidence of MRSA was stable and low (0.137 per 100 admissions). The prevalence of Panton-Valentine leukocidin (PVL)-positive MRSA was high (33.8 %). The 26 PVL-positive MRSA were genetically diverse, with two clones being predominant: ST80 (12 isolates, 46.1 %) and ST8-USA300 (8 isolates, 30.8 %). The incidence of ST8-USA300 increased over the 6-year period. We believe that screening for ST8-USA300 should be improved: medical biologists should be encouraged to search for PVL genes in all MRSA isolates recovered from abscesses, whatever the susceptibility pattern of the isolate, and not only when suggestive of ST80.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
---|---|
Enthalten in: |
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology - 34(2015), 5 vom: 12. Mai, Seite 935-42 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
van der Mee-Marquet, N [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bacterial Toxins |
---|
Anmerkungen: |
Date Completed 11.01.2016 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10096-014-2308-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM245224394 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM245224394 | ||
003 | DE-627 | ||
005 | 20231224140417.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10096-014-2308-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n0817.xml |
035 | |a (DE-627)NLM245224394 | ||
035 | |a (NLM)25575950 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a van der Mee-Marquet, N |e verfasserin |4 aut | |
245 | 1 | 4 | |a The incidence of Staphylococcus aureus ST8-USA300 among French pediatric inpatients is rising |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.01.2016 | ||
500 | |a Date Revised 13.11.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Methicillin-resistant Staphylococcus aureus (MRSA) formerly colonized and infected only inpatients in hospitals, but have been reported in community settings worldwide over the last 20 years. In France, the prevalence of such MRSA remains low and outbreaks have, until now, been mainly due to the ST80 clone. However, there were two outbreaks of MRSA clone ST-USA300 recently in France, including one involving children. To investigate epidemiological developments, we studied the 77 MRSA isolated from pediatric patients hospitalized between 2008 and 2013 in three French hospitals. The median incidence of MRSA was stable and low (0.137 per 100 admissions). The prevalence of Panton-Valentine leukocidin (PVL)-positive MRSA was high (33.8 %). The 26 PVL-positive MRSA were genetically diverse, with two clones being predominant: ST80 (12 isolates, 46.1 %) and ST8-USA300 (8 isolates, 30.8 %). The incidence of ST8-USA300 increased over the 6-year period. We believe that screening for ST8-USA300 should be improved: medical biologists should be encouraged to search for PVL genes in all MRSA isolates recovered from abscesses, whatever the susceptibility pattern of the isolate, and not only when suggestive of ST80 | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Bacterial Toxins |2 NLM | |
650 | 7 | |a Exotoxins |2 NLM | |
650 | 7 | |a Leukocidins |2 NLM | |
650 | 7 | |a Panton-Valentine leukocidin |2 NLM | |
700 | 1 | |a Poisson, D-M |e verfasserin |4 aut | |
700 | 1 | |a Lavigne, J-P |e verfasserin |4 aut | |
700 | 1 | |a Francia, T |e verfasserin |4 aut | |
700 | 1 | |a Tristan, A |e verfasserin |4 aut | |
700 | 1 | |a Vandenesch, F |e verfasserin |4 aut | |
700 | 1 | |a Quentin, R |e verfasserin |4 aut | |
700 | 1 | |a Bertrand, X |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology |d 1988 |g 34(2015), 5 vom: 12. Mai, Seite 935-42 |w (DE-627)NLM012620742 |x 1435-4373 |7 nnns |
773 | 1 | 8 | |g volume:34 |g year:2015 |g number:5 |g day:12 |g month:05 |g pages:935-42 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10096-014-2308-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 34 |j 2015 |e 5 |b 12 |c 05 |h 935-42 |